Detalhe da pesquisa
1.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767
2.
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Cancer
; 124(11): 2407-2414, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579334
3.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
Oncologist
; 22(4): 375-e30, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275117
4.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(3): 367-377, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874901
5.
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.
Nat Genet
; 37(12): 1315-6, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16258541
6.
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Lancet Oncol
; 14(11): 1121-1128, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24007746
7.
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Eur J Cancer
; 184: 48-59, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898233
8.
Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer.
medRxiv
; 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808694
9.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
Oncologist
; 22(10): 1281, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018169
10.
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.
Clin Cancer Res
; 19(1): 258-67, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23082002
11.
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Cancer
; 116(10): 2301-6, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20225231
12.
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.
J Clin Oncol
; 28(21): 3485-90, 2010 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498386
13.
Estudio comparativo de la prevalencia de aterosclerosis en la ciudad de Guatemala y en Nueva Orleans / Comparitive study of the atherosclarosis in Guatemala city and New Orleans
Boletín de la Oficina Sanitaria Panamericana (OSP)
; 46(Suplemento No. 3),mar. 1959 Tab
Artigo
| PAHOIRIS | ID: phr-14838
14.
La evaluacion cuantitativa de la ateroesclerosis / The quantitative evaluation of atherosclarosis
Boletín de la Oficina Sanitaria Panamericana (OSP)
; 46(Suplemento No. 3),mar. 1959 Tab
Artigo
| PAHOIRIS | ID: phr-14837
15.
Estudio comparativo de la prevalencia de aterosclerosis en la ciudad de Guatemala y en Nueva Orleans / Comparitive study of the atherosclarosis in Guatemala city and New Orleans
Boletín de la Oficina Sanitaria Panamericana (OSP)
; 46(Suplemento No. 3): 133-38, mar. 1959. Tab
Artigo
em Espanhol
| PAHO | ID: pah-34349
16.
La evaluacion cuantitativa de la ateroesclerosis / The quantitative evaluation of atherosclarosis
Boletín de la Oficina Sanitaria Panamericana (OSP)
; 46(Suplemento No. 3): 139-47, mar. 1959. Tab
Artigo
em Espanhol
| PAHO | ID: pah-34350
17.
Geographic differences in the severity of aortic and coronary atherosclerosis
Am J Pathol
; 36(5): 559-74, May 1960.
Artigo
em Inglês
| MedCarib | ID: med-14487